Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Flaherty, PharmD
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Heritage Medical Research Clinic
Calgary, Alberta, Canada
- the Gordon & Leslie Diamond Centre
Vancouver, British Columbia, Canada
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- Toronto General Hospital
Toronto, Ontario, Canada
- Hopital Conception
Marseille, France
- Medizinische Klinik Mit Schwerpunkt Hepatologie Und Gastroenterologie
Berlin, Germany
- Universitat Heidelberg
Heidelberg, Germany
- Johannes Gutenberg-Universitat
Mainz, Germany
- General Hospital of Athens "ippokratio"
Athens, Greece
- Universita de Padova
Padova, Italy
- Policlinico Universitario
Udine, Italy
- Wojewodzki Szpital Specjalistyczny Im Dluskeigo
Bialystok, Poland
- Wojewodzki Szpital Obserwacy
Bydgoszcz, Poland
- Wojewodzki Szpital Zakazny
Warsaw, Poland
- Changi General Hospital
Singapore, Singapore
- National University Hospital Dept. of Gastroenterology & Hepatology
Singapore, Singapore
- Singapore General Hospital
Singapore, Singapore
- Tan Tock Seng Hospital
Singapore, Singapore
- Hospital Clinic I Provincial de Barcelona (hcpb)
Barcelona, Spain
- Hospital General Universitari Vall D'Hebron
Barcelona, Spain
- Hospital Universitario de Bellvitge
Barcelona, Spain
- Hospital General Universitario Gregorio Maranon
Madrid, Spain
- Hospital Universitario Y Politecnico la Fe
Valencia, Spain
- Chang Gung Memorial Hospital - Kaohsiung
Kaoshiung Hsien, Taiwan
- National Cheng Kung University Hospital
Tainan, Taiwan
- Cathay General Hospital
Taipei, Taiwan
- Chang-Gung Memorial Hospital
Taipei, Taiwan
- Marmara Universitesi School of Medicine
Istanbul, Turkey (Türkiye)
- Ege Universitesi Tip Fakultesi Hastanesi
Izmir, Turkey (Türkiye)
- Pfleger Liver Institute
Los Angeles, California, United States
- California Pacific Medical Center Research Institute
San Francisco, California, United States
- University of Miami, Center for Liver Diseases
Miami, Florida, United States
- Rush Presbyterian - St. Luke'S Medical Center
Chicago, Illinois, United States
- Henry Ford Hospital and Health System
Detroit, Michigan, United States
- Columbia Presbyterian Medical Center
New York, New York, United States
- Mt. Sinai School of Medicine/ Mt. Sinai Medical Center
New York, New York, United States
- Metropolitan Research
Fairfax, Virginia, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2006
- Primary completion
- 30 Apr 2011
- Completion
- 30 Apr 2011
- Last update posted
- 25 Apr 2013
- Registered enrollment
- 112
- Registry id
- NCT00298363
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.